nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absence of cardiotoxicity with prolonged treatment and large accumulating doses of pegylated liposomal doxorubicin
|
Blank, N. |
|
2017 |
80 |
4 |
p. 737-743 |
artikel |
2 |
Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis
|
Abdel-Daim, Mohamed M. |
|
2017 |
80 |
4 |
p. 745-753 |
artikel |
3 |
Antiangiogenic tyrosine kinase inhibitors in colorectal cancer: is there a path to making them more effective?
|
Karasic, Thomas B. |
|
2017 |
80 |
4 |
p. 661-671 |
artikel |
4 |
A phase II study of modified docetaxel, cisplatin, and S-1 (mDCS) chemotherapy for unresectable advanced gastric cancer
|
Uemura, Naoki |
|
2017 |
80 |
4 |
p. 707-713 |
artikel |
5 |
A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men
|
Markus, Richard |
|
2017 |
80 |
4 |
p. 755-763 |
artikel |
6 |
Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value
|
Skubitz, Keith M. |
|
2017 |
80 |
4 |
p. 787-798 |
artikel |
7 |
Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea
|
Lee, Kyong Joo |
|
2017 |
80 |
4 |
p. 799-805 |
artikel |
8 |
Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer
|
Tagawa, Nao |
|
2017 |
80 |
4 |
p. 841-849 |
artikel |
9 |
Comparison of the RECIST and EORTC PET criteria in the tumor response assessment: a pooled analysis and review
|
Kim, Jung Han |
|
2017 |
80 |
4 |
p. 729-735 |
artikel |
10 |
Continuous low plasma concentrations of everolimus provides equivalent efficacy to oral daily dosing in mouse xenograft models of human cancer
|
Laborde, Laurent |
|
2017 |
80 |
4 |
p. 869-878 |
artikel |
11 |
Depth of response predicts the clinical outcome of advanced HER2-positive gastric cancer to trastuzumab-based first-line chemotherapy
|
Kadowaki, Shigenori |
|
2017 |
80 |
4 |
p. 807-813 |
artikel |
12 |
Hyponatremia and V2 vasopressin receptor upregulation: a result of HSP90 inhibition
|
Yang, Qiong |
|
2017 |
80 |
4 |
p. 673-684 |
artikel |
13 |
Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer
|
Danno, Katsuki |
|
2017 |
80 |
4 |
p. 777-785 |
artikel |
14 |
MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells
|
Rajabpour, Azam |
|
2017 |
80 |
4 |
p. 765-775 |
artikel |
15 |
Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia
|
Ben Hassine, Islem |
|
2017 |
80 |
4 |
p. 829-839 |
artikel |
16 |
Novel formulation of abiraterone acetate might allow significant dose reduction and eliminates substantial positive food effect
|
Solymosi, Tamás |
|
2017 |
80 |
4 |
p. 723-728 |
artikel |
17 |
Optimism and the continued promise of maintenance chemotherapy
|
Micha, John P. |
|
2017 |
80 |
4 |
p. 879-880 |
artikel |
18 |
Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma
|
Badruddoja, Michael A. |
|
2017 |
80 |
4 |
p. 715-721 |
artikel |
19 |
Significance of glucocorticoid receptor expression in patients with non-small cell lung cancer treated with pemetrexed-based chemotherapy
|
Zhao, Xin-min |
|
2017 |
80 |
4 |
p. 851-860 |
artikel |
20 |
Superactive human leptin antagonist (SHLA), triple Lan1 and quadruple Lan2 leptin mutein as a promising treatment for human folliculoma
|
Fiedor, E. |
|
2017 |
80 |
4 |
p. 815-827 |
artikel |
21 |
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
|
Srinivasan, Gayathri |
|
2017 |
80 |
4 |
p. 861-867 |
artikel |
22 |
The concept of platinum sensitivity could be applied to recurrent cervical cancer: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group
|
Takekuma, Munetaka |
|
2017 |
80 |
4 |
p. 697-705 |
artikel |
23 |
Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer
|
Huang, Shengshi |
|
2017 |
80 |
4 |
p. 685-696 |
artikel |